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Careful examination of relevant literature shows that many of the most cherished concepts
of the blood-brain barrier are incorrect. These include an almost mythological belief in
its immaturity that is unfortunately often equated with absence or at least leakiness in
the embryo and fetus. The original concept of a blood-brain barrier is often attributed to
Ehrlich; however, he did not accept that permeability of cerebral vessels was different
from other organs. Goldmann is often credited with the first experiments showing dye
(trypan blue) exclusion from the brain when injected systemically, but not when injected
directly into it. Rarely cited are earlier experiments of Bouffard and of Franke who showed
methylene blue and trypan red stained all tissues except the brain. The term “blood-brain
barrier” “Blut-Hirnschranke” is often attributed to Lewandowsky, but it does not appear
in his papers. The first person to use this term seems to be Stern in the early 1920s.
Studies in embryos by Stern and colleagues, Weed and Wislocki showed results similar to
those in adult animals. These were well-conducted experiments made a century ago, thus
the persistence of a belief in barrier immaturity is puzzling. As discussed in this review,
evidence for this belief, is of poor experimental quality, often misinterpreted and often
not properly cited. The functional state of blood-brain barrier mechanisms in the fetus
is an important biological phenomenon with implications for normal brain development.
It is also important for clinicians to have proper evidence on which to advise pregnant
women who may need to take medications for serious medical conditions. Beliefs in
immaturity of the blood-brain barrier have held the field back for decades. Their history
illustrates the importance of taking account of all the evidence and assessing its quality,
rather than selecting papers that supports a preconceived notion or intuitive belief. This
review attempts to right the wrongs. Based on careful translation of original papers, some
published a century ago, as well as providing discussion of studies claiming to show
barrier immaturity, we hope that readers will have evidence on which to base their own
conclusions.
Keywords: blood-brain barrier, blood-cerebrospinal fluid barrier, embryo, fetus, newborn, permeability, tight
junctions, transporters
INTRODUCTION
The very first studies of barrier properties in embryos clearly
demonstrated the intactness of the interfaces between the blood,
brain and cerebrospinal fluid1. Thus Wislocki (1920) injected
a guinea pig embryo with trypan blue (Figure 1A), the same
Abbreviations: CNS, central nervous system; CSF, cerebrospinal fluid; HRP,
horseradish peroxidase.
1Where possible we have worked from original references. Where these were
not in English we have given citations of key points in the original language,
together with a translation (indicated by italics). Readers will be able to decide
for themselves if the translations are accurate and if our deductions from the
citations are appropriate.
dye, which was first used by Goldmann (1909; 1913 see below).
Wislocki (1920) observed that in the embryo, as in adult ani-
mals, the dye stained almost all of the tissues of the body, with
the notable exception of much of the brain.
Even earlier than this Weed (1917a,b) injected an approx-
imately isotonic solution of potassium ferrocyanide, a small
molecule about the same size as sucrose, into the neural tube
of E19 and older pig embryos. Weed’s results showed that in
an E19 pig embryo the potassium ferrocyanide (demonstrated
by the Prussian blue reaction) remained entirely within the
fluid filling the neural tube (Figure 1B). This suggests that even
this early in development, shortly after neural tube closure, the
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FIGURE 1 | Early demonstration of blood-brain barrier phenomenon in
developing brain. (A) Mid gestation guinea pig embryo injected with
trypan blue (Wislocki, 1920). Note lack of staining of brain and spinal
cord as previously described in adult animals injected with trypan blue
(Goldmann, 1909), methylene blue (Bouffard, 1906) and trypan red
(Franke, 1905). (B) Very early pig embryo (9mm, E19) injected with
isotonic sodium ferrocyanide into spinal canal (arrow) treated with acid
(Prussian blue reaction). Note that blue reaction product is confined to
CSF, with a small amount of diffusion into brain stem and mid brain
tissue, but no staining of somatic tissue. This indicates that the CNS is
already a closed compartment separate from the rest of the embryo.
From Weed (1917b).
central nervous system (CNS) is separate from the rest of the
embryo.
Similar results were obtained in chick embryos by Cohen and
Davies (1938). The experiments of Wislocki, Weed and Cohen
and Davies are the developmental equivalent of what are some-
times described as Goldmann’s 1st and 2nd experiments, in which
he reported iv injection (1909) and intrathecal injection (1913) of
trypan blue in adult animals of various species. The evidence from
the experiments of Weed, Wislocki, Chen and Davies in develop-
ing animals for the existence of a barrier between the blood and
brain and blood and CSF was as convincing as Goldmann’s exper-
iments in adult animals. Yet at some point a belief, which has
persisted for nearly 100 years, arose that in embryos, fetuses and
even in the newborn and older, the blood-brain barrier is absent,
leaky or immature (e.g., Statz and Felgenhauer, 1983; Adinolfi,
1985; Davies and Rudd, 1994; Rodier, 1994, 1995, 2004; Ahmed
et al., 1996; ATSDR, 1999, 2007, 2014; Järup, 2003; Costa et al.,
2004; Watson et al., 2006; Mhanna et al., 2008; Baldrick, 2010;
Ehman, 2010; Srinivasan et al., 2012). These and other authors
appear to equate immaturity with “leakiness.” The developing
brain in all respects is by definition yet to reach a mature adult
state and therefore can rightly be described as immature. But this
does not tell us whether its brain barriers are “leaky.” The real
question is their functional status, which seems to us to be more a
matter of the relation between barrier functions (which are much
more than the presence or absence of passive permeability) that
are present at any particular age and stage of brain development.
We wondered why such a dogma continues to be accepted in view
of overwhelming experimental evidence to the contrary gathered
over many decades, for as pointed out by Dobbing (1961): “There
has never been a shred of satisfactory evidence in favor of this
proposition.”
The general explanation seems to be a philosophical rather
than an experimentally based one. There seems to have been an
underlying assumption, often not clearly enunciated, that because
the embryonic and newborn brains are developing, adult bar-
rier mechanisms would necessarily be immature or absent. This
was most explicitly stated in “The brain and its environment”
by the English physiologist Barcroft (1938): “There is no reason
why the brain of the embryo should require an environment of
very great chemical constancy. It will of course require a certain
minimum of the various materials necessary for growth, but oth-
erwise on first principles we might suppose that the good things
of life may exist in and may vary in fetal blood to an extent
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much greater than in the maternal.” However, this is a teleolog-
ical argument, implying need/requirement or in this case, lack of
need/requirement. One could as well argue that a complex organ
like the brain would need (require) a specialized environment in
which to develop rather than the general “soup” of the embryo
as a whole. However, neither argument has any intellectual merit
as they are based on opinion rather than experimental evidence.
More recently, and in the face of much evidence to the contrary
since Barcroft’s time, Zheng (2002) has put forward a similar tele-
ological argument: “During early development, the rapid growth
of the cerebral cortex perhaps necessities a “leaky” structure of the
BBB to accommodate the high demand of blood-borne nutrients
for brain growth.” However, as we discuss below, the greater entry
of some amino acids into the developing brain is a reflection of
much higher expression of their transporters in brain endothelial
and choroid plexus epithelial cells. This higher expression, which
indicates a developmental specialization, is likely to be a reflection
of the importance of amino acids for developing brain rather than
a manifestation of a non-specific leak.
CONCEPT OF THE BLOOD-BRAIN BARRIER
Before dealing with experimental evidence of brain barriers dur-
ing development we need to consider the concept of the adult
blood-brain barrier itself. This is often attributed to Ehrlich on
the basis of his experiments with dyes (e.g., Gröntoft, 1954; Bakay,
1956; Dempsey and Wislocki, 1955; Lee, 1971; Davson et al.,
1987; Risau and Seulberger, 1990; Risau and Wolburg, 1990;
Hawkins and Davis, 2005; Nag, 2011). However, as pointed out by
Bradbury (1995); Ehrlich (1885, 1906) himself never subscribed
to the view that the lack of staining of the brain by parenterally
administered dyes could be ascribed to some special property of
the cerebral endothelial cells. This idea was proposed by Biedl
and Kraus (1898); Roux and Borrel (1898), and Lewandowsky
(1900) based on comparison of intrathecal and parenteral injec-
tions of materials with neurotoxic effects, such as bile salts, after
injection by the former route. This was specifically rejected by
Ehrlich: “I am unable to accept that the vascular endothelium,
as such, exercises different functions in different organs, so that,
for example a liver capillary is permeable for certain substances
that will not pass through other capillaries” (Ehrlich, 1906). This
seems a rather curious conclusion given the description of some
of his earlier dye studies (Ehrlich, 1885). In his extensive MD the-
sis (“Habilitationsschrift”) Ehrlich was primarily using dyes as a
means of determining the oxygen usage in different organs by
their color change (low oxygen or reduction resulting in a col-
orless state of the dye and on oxygenation resulted in the reverse).
He used mainly Alizarin Blue-S (a compound of Alizarin blue
and sodium bisulfite) and Indophenol white (which became blue
when exposed to oxygen), injected usually subcutaneously into
animals of various species. Both of these dyes stained the brain
blue, exclusively in gray matter. Under conditions of reduced oxy-
gen (as post mortem) the dyes became colorless. Ehrlich also used
dyes treated with acids or heavy metals to give larger particle
sizes-alizarin-sodium sulfite-alum and Coerulin-S. These did not
stain the brain following subcutaneous injection. To explain this
Ehrlich proposed, that “the brain was the most “finely porous”
of the organs” he studied. Ehrlich does not say if these “pores”
were in blood vessel walls or some other interface between blood
and brain tissue. Later Ehrlich (1906) reported on a much larger
number of dyes and concluded that acid dyes (with the excep-
tion of alizirin) did not stain the gray matter of the brain whereas
many basic dyes did. He suggested that dye experiments could be
explained by lack of affinity of brain tissue for the dyes rather than
to a special property of brain blood vessels. So perhaps Ehrlich
could best be described as the reluctant discoverer of the blood-
brain barrier phenomenon, but not as the originator of the term
“blood-brain barrier.”
Many authors, including Spatz (1934), Broman (1941),
Davson (1967), Davson et al. (1987), Hawkins and Davis (2005),
Engelhardt (2003, 2006), Ribatti et al. (2006), Saunders et al.
(2012) have attributed the term “Blut-Hirnschranke” (blood-
brain barrier) to Lewandowsky’s (1900) publication.
Lewandowsky (1900) used strychnine and sodium ferro-
cyanide, in much higher doses than the potassium ferrocyanide
used by Weed (1917b), who stated that in his experiments it
was not toxic. Lewandowsky demonstrated in a variety of ani-
mal species that the toxins were effective in much lower doses
when injected into the brain than parenterally. He also attributed
the lesser penetration of strychnine and sodium ferrocyanide
into the brain following subcutaneous injection compared to
subarachnoid injection to a difference in the properties of the
cerebral vessels compared to other tissues: “. . . die Hypothese
dass die Cappillarwand den Uebertritt bestimmter Stoffe, wie
des Natriumferrocyanats verhindert, oder mit anderen Worten,
dass seine Affinitat der Capillarzellen des Centralnervensystems
nothwendig ist um bestimmte Stoffe an die Nervenzellen hin-
durchgelangen zu lassen.”: the hypothesis that the capillary wall
blocks the transfer of certain molecules like sodium ferrocyanide or
in other words, that an affinity of capillary cells of the CNS is nec-
essary in order to allow the transfer of certain molecules to nerve
cells. A close reading of Lewandowsky’s original paper reveals that
the term “Blut-Hirnschranke” was not actually used, although as
indicated by the above quotation, Lewandowsky clearly proposed
that cerebral capillaries have specific restrictive properties with
respect to some compounds.
The first use of the term “barrier” appears to be by Stern
and Gautier (1918a,b), the latter paper is entitled “La barrière
qui s’oppose au passage dans le liquide céphalo-rachidien de
substances circulant dans le sang présente des différences nota-
bles suivant les espèces animales”: The barrier which opposes the
movement into the CSF of substances in the blood shows notable
differences in different animal species (Stern and Gautier, 1918b).
Stern and colleagues subsequently performed detailed studies of
penetration of a wide range of molecules from blood into cere-
brospinal fluid (Stern and Gautier, 1921) into brain (Stern and
Gautier, 1922) and within the subarachnoid and ventricular CSF
(Stern and Gautier, 1923) of adult animals. It was Stern who first
described the importance of the interstitial fluid environment of
the brain for its normal function, very much in the tradition of
Claude Bernard’s milieu interne (1865).
Malamud et al. (1928), Franceschini (1929) and Joó (1987)
appear to be among only a few authors to have acknowledged that
Stern was probably the first to coin the term blood-brain barrier
(“barrière hémato-encéphalique,” Stern and Gautier, 1921). Stern
www.frontiersin.org December 2014 | Volume 8 | Article 404 | 3
Saunders et al. History of blood-brain barrier concepts and misconceptions
and Gautier were careful to point out that this term did not
prejudge either the anatomical nature or functional mechanisms
involved. The term “blood-brain barrier” has withstood the test
of time, notwithstanding that to people outside the field it is
misleading in that it implies an absolute impediment to entry
into the brain and does not make it explicitly clear that exchange
mechanism are involved—exactly as supposed by Stern when she
proposed the term. However, Stern’s important contributions to
the field of blood-brain barrier biology have either been largely
ignored or belittled (see below).
In addition to Lewandowsky’s 1900 experiments, Biedl and
Kraus (1898) injected bile and bile acids either systemically or
directly into the brain. Only in the case of the latter did they
see any toxic effects. They ascribed the ineffectiveness of system-
ically injected bile salts to “the relative impermeability of the
capillary walls,” although they did not use the term “barrier” to
describe this effect. Roux and Borrel (1898) reported on the com-
parison of subcutaneous and subdural injections of tetanus toxin
with the finding that much less toxin is required to provoke cen-
tral manifestations of tetanus, but only in rabbits; other species
were unaffected. Their explanation for the difference was “sans
doute, à ce que beaucoup du poison introduit n’arrive pas aux
cellules nerveuses et est detruit quelque part dans l’organisme.”:
without doubt little of the toxin reaches nervous tissue and is
destroyed elsewhere in the organism. However, they did not com-
ment on the mechanism that prevented toxin from reaching the
brain.
Amongst the most cited papers for the concept of the
blood-brain barrier are those of Goldmann (1909, 1913). He
compared distribution of the dye trypan blue following par-
enteral or intrathecal injection. These are sometimes referred
to as Goldmann’s first and second experiments (Davson, 1976;
Bradbury, 1979). Goldmann found that parenterally injected dye
did not stain the brain (Goldmann, 1909), whereas it did when
injected into the subarachnoid space, (Goldmann, 1913) as illus-
trated in Figure 2. Goldmann is usually given the credit for being
the first to use a dye to demonstrate that some dyes admin-
istered parenterally do not enter the brain. Goldmann himself
acknowledges earlier dye studies of Bouffard (1906) but incor-
rectly states that Bouffard used trypan blue. Bouffard makes an
unreferenced mention of even earlier studies with trypan red
and Congo red and describes his own studies with methylene
blue. Bouffard (1906) injected this dye by various routes (subcu-
taneous, intravenous, intramuscular or intracardiac) into mice,
guinea pigs and rabbits in single or multiple doses of increas-
ing size. He reported unequivocally that there was no staining
of the nervous tissue: “SYSTEME NERVEUX.—Aucune trace
de couleur, ni dans les cellules nerveuses, ni dans les éléments
FIGURE 2 | Goldmann’s trypan blue injection experiments. (A)
Adult rat following systemic injection of trypan blue solution
(Goldmann’s “1st experiment”). From Goldmann (1909). (B) Brain
and spinal cord of adult rat following lumbar subarachnoid injection
of 0.5ml, 0.5% trypan blue (Goldmann’s “2nd experiment”). From
Goldmann (1913).
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névrogliques.” Bouffard did not report any toxic effects of methy-
lene blue and did not seem to suggest any mechanism to explain
the lack of staining of the nervous system. Bouffard (1906) men-
tioned, but did not reference, an even earlier study by a student
of Ehrlich’s, Franke, who used trypan red. According to Bouffard,
Franke also showed that the dye did not enter the brain although
it did enter most other tissues and organs. This citation appears
to have been taken from Franke’s (1905) thesis, in which Franke
stated “Das Trypanrot gehört zu den polytropen Farbstoffen im
Sinne EHRLICHS; es wird entsprechend den Beobachtungen,
die bei anderen saueren Farbstoffen gemacht worden sind, von
allen Organen mit Ausnahme des Nervensystems, aufgenom-
men”: Trypan red belongs to the polytropic dyes according to Ehrlich;
it is taken up,- as observed with other acidic dyes, by all organs
except the nervous system. None of these authors seems to have
offered any explanation of the lack of staining of the brain by
the different dyes; indeed Goldmann (1913) appears to have
been surprised by this observation: “Es ist mir rätselhaft dass
grosse Farbstoffmengen, welche bei der intravenösen Applikation
in den Gehirngefässen zirkulieren, selbst die feinste Kapillarwand
nicht zu durchdringen vermögen”: I fail to understand why high
concentrations of dye circulating in the blood vessels after intra-
venous injection are unable to penetrate even the walls of the finest
capillaries (Goldmann, 1913, p. 45).
Goldmann (1913) did however, remark on the strong staining
of the choroid plexus with trypan blue and suggested this rep-
resented the site at which dyes were prevented from entering the
brain. Goldmann (1909, 1913) reported toxic effects with injected
trypan blue and commented that the toxic effects that occurred
following subarachnoid injections of the dye were made with
amounts of trypan blue that were much less than when injected
intravenously, particularly in rabbits. Because the choroid plexus
stained very strongly with the dye, Goldmann suggested that it
was primarily the choroid plexus that provided a protective mech-
anism for the brain and that this was the route by which some
substances entered the brain. This subsequently led to the use of
the term “Weg über den Liquor,” although not by Goldmann or
by von Monakow to whom it is sometimes attributed.
But Goldmann clearly thought that the choroid plexuses
had a protective role in preventing entry of toxic mate-
rials into the brain: “Der Plexus vermag andererseits die
Zerebrospinalflüssigkeit und damit die Nervensubstanz vor dem
Eindringen von Substanzen zu schützen, die sich bei der direk-
ten Einfuhr in den Subarachnoidealraum als ein schweres Gift
für die Ganglienzellen erweisen.” (Goldmann, 1913, p. 54): On
the other hand the choroid plexus is capable to protect the liquor
and therefore also the nervous substance against the influx of sub-
stances which when directly transferred into the subarachnoid space
are a strong toxin for the ganglionic cells. He then summarizes
his view of the choroid plexus as a protective regulatory mech-
anism: “Wir kommen somit zu dem Schluß, dass der Plexus
ein wichtiger Schutz-und Regulationsmechanismus für das zen-
trale Nervensystem darstellt, und dass differenten Substanzen
Tür und Tor für ihren Eintritt in das zentrale Nervensystem
geöffnet werden, wenn die physiologische Eintrittspforte, der
Plexus chorioideus, umgangen wird und solche differente Stoffe
durch die Lumbalpunktion in eine direkte Berührung mit den
Nervenelementen gebracht warden.” (Goldmann, 1913, p. 55):
Thus we conclude that the plexus is an important protective-and
regulatory mechanism for the CNS and that various substances will
freely enter the CNS if the physiological gatekeeper, the choroid
plexus, is circumvented by a lumbar puncture, those substances
will come into direct contact with the nervous elements. However
it should be noted that Goldmann makes no mention of any
protective function of cerebral blood vessels.
ROUTE OF ENTRY FROM BLOOD INTO BRAIN
Stemming from the studies of Goldmann (1909, 1913) described
above and supported by vonMonakow (1921) there came the sug-
gestion that the choroid plexuses, rather than the cerebral blood
vessels, were the CNS protective mechanism and the primary
route of entry of nutritive substances into the brain (described
by the term “Weg über den Liquor” by later authors). However,
this proposed nutritive function of the choroid plexus seems to
have been current earlier than this (see Meek, 1907). Stern in
particular initially supported this idea in her interpretation of
extensive studies of entry of a wide range of molecules from
blood into CSF (Stern and Gautier, 1921) and brain (Stern and
Gautier, 1922) in which she emphasized the importance of the
choroid plexuses in this role. Davson (1956, 1976) considered this
an untenable hypothesis and dismissed the idea as “intellectu-
ally inadequate” as it did not take account of substantial vascular
circulation of the brain parenchyma. This view was shared by
Friedemann (1942): “It is utterly unlikely that in an organ of
the vital importance of the brain the capillaries should lack their
chief uses, namely, mediation of the exchange between blood
and tissue and adaptation of blood supply to functional needs”
(Friedemann, 1942, p. 126). The idea was also dismissed by sev-
eral other German authors (e.g., Friedemann and Elkeles, 1931,
1934; Walter, 1934). However, this dismissal is not justified, as
these authors have ignored or miss-cited Stern and Rapoport’s
short papers (e.g., Stern and Rapoport, 1928a,b) from which it is
clear that they believed in the existence of two routes of entry from
blood into brain: one directly across the blood vessels (endothe-
lial blood-brain barrier) and the other via the choroid plexuses
(Goldmann and Stern’s blood-brain barrier, now referred to as
the epithelial blood-cerebrospinal fluid-barrier). For example,
Stern and Rapoport (1928a) reported that in animals subjected
to carbon monoxide poisoning, dyes entered brain tissue directly
across the cerebral blood vessels, but only sodium ferrocyanide
could be detected in the CSF, which was interpreted as sug-
gesting two different routes of entry into the brain, one (for
trypan blue or similar colloids) at the vascular endothelial cells
of brain capillaries, the other (for sodium ferrocyanide) via the
plexuses.
In Geneva Lina Stern, who was a physiologist and biochemist,
did not have anybody in her laboratory to perform a thorough
post-mortem histology of the brain of the experimental animals.
In Moscow she found a competent neuropathologist/histologist
Yakov Rapoport, who could localize which cells in the brain had
been colored by the injected trypan blue or had been revealed
by the Prussian blue reaction. His contribution was therefore
of great importance. Unfortunately their cooperation came to
an end in the early 1930’s. It seems likely that the two dis-
agreed on the respective roles of the blood-CSF and blood-brain
barriers.
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In contradistinction to her previous short papers with
Rapoport, on the “two barriers model,” Stern in a short paper
(1934) focused her attention on the blood-CSF barrier (which
she calls the barrière hémato-encéphalique). Stern admits that the
use of dyes or of other yes-or-no biological markers to assess
the permeability of the barrière hémato-encéphalique (blood-
CSF barrier) is open to criticism. “En effet il n’est guère possible
de tirer des conclusions sur le comportement du liquide en par-
tant simplement de la pénétration ou de la non-pénétration d’une
substance donnée présente [dans le plasma sanguin].”: Actually
the composition of the liquid cannot be directly deduced from the
passage or non-passage of a substance present in blood plasma.
According to Stern (1934), the barrier has dual roles of pro-
tection and metabolic regulation of the brain. She also introduces
the notions of barrier selectivity and barrier resistance. Thus in
this 1934 paper, which was one of the last published in French,
Stern makes a very clear statement about the importance of
the blood-brain barrier in not only providing protection for the
brain but also an appropriate physico-chemical environment for
normal brain function: “Partant de l’idée que le liquide céphalo-
rachidien represénte le milieu nutritif immédiat des éléments
nerveux cérébro-spinaux et que la constance relative de la com-
position chimique et de l’état physico-chimique de ce milieu est
une condition sine qua non du fonctionnment normal des centers
nerveux, nous avons attributé un rôle de premier plan à l’activité
de cet appareil régulateur que représente la barrière hémato-
encéphalique.”: Starting with the idea that the CSF represents the
immediate nutritive medium for the cells of the brain and spinal
cord and that the relative constancy of the chemical composition and
physico-chemical state of this medium is the sine qua non for nor-
mal function of the CNS we have attributed a primary role for this
regulatory activity to the blood-brain barrier. The concept of the
blood-brain barrier providing mechanisms that control the inter-
nal environment of the brain is a major physiological concept that
was decades ahead of its time and really only began to be properly
accepted and investigated with the advent of radioactive tracers in
the 2nd half of the 20th Century as outlined below.
Stern (1934) does not mention the relative importance of
the cerebral vessels (blood-brain barrier) and choroid plexuses
(blood-CSF barrier) in these dual functions of protection and reg-
ulation of the internal environment of the brain. This remains a
technical difficulty to this day. It does seem highly unsatisfactory
that later authors did not take account of Stern’s direct studies
on permeability of the cerebral blood vessels under both nor-
mal and pathological conditions. Another extremely important
point made by Stern (1934) was her insistence on the necessity
of appreciating that the barrier does not have uniform proper-
ties with respect to the wide range of molecules that she studied
in earlier works: “. . . le fonctionnement de la barrière ne présente
pas un caractère uniforme vis à vis de toutes les substances exam-
inées. . . ”: the function of the barrier is not uniform with respect to
all substances studied. This is an extremely important point, which
is often still not realized to this day.
In contrast to the adult brain, in the developing brain it is now
clear that the choroid plexuses are indeed the main portal of entry
into the brain (Johansson et al., 2008). As will be recounted below,
after returning from Geneva to Moscow in 1925 (Dreifuss and
Sigrist, 2009) Stern made important contributions to the study of
brain barriers in developing animals of a number of species in a
series of short papers published in the period 1927–1929. If more
notice had been taken of Stern’s papers, the longstanding belief in
the absence of the blood-brain barrier in the fetus and newborn
might have been short-lived.
EARLY DYE STUDIES IN IMMATURE ANIMALS
The important paper of Wislocki (1920), discussed above and
illustrated in Figure 1A, was rarely cited in most of the litera-
ture of the 20th Century, perhaps because it did not fit with
the prevailing belief in immaturity of the blood-brain barrier.
Even King (1939), who published with Wislocki, does not men-
tion the seminal 1920 paper preferring instead to cite Behnsen
(1927) as evidence of barrier immaturity; the deficiencies of the
latter study are discussed next. These are perhaps the most cited
in support of immaturity or leakiness of the blood-brain barrier
(Behnsen, 1926, 1927) particularly his 1927 paper (e.g., Spatz,
1934; King, 1939; Friedemann, 1942; Davson, 1967). In the 1926
paper Behnsen refers to sealing (“Abdichtung”) of the barrier in
the postnatal animals, and writes in the summary on page 1146
that the blood brain barrier is considerably more leaky (orig-
inal: “erheblich durchlässiger”) than in adult mice as staining
with trypan blue appears in young animals more intense gen-
erally and also in different places of the CNS compared to the
staining pattern of adults. However, in some slightly handicapped
adult mice Behnsen also found additional areas in the brain which
were stained, that he called those weak spots (orig. “schwache
Stellen”), besides those where apparently no barrier exists (orig.
“offene Stellen”) and puts this in contrast to Goldmann’s view
that the central nervous is entirely sealed from dye (Goldmann,
1909, 1913). He also suggested: The fact that the blood-brain
barrier in the young is more leaky may also relate to immatu-
rity of tissues and cells and a different level of cellular maturity.
(orig.: “Im Speicherverhalten der nervösen Zellen zeigen sich
Unterschiede, die . . . auf einen verschiedenen Reifezustand der
Zellen zu beziehen sind,” Behnsen, 1926. p. 1146). It may be that
Behnsen’s finding of dye in some parts of the brain was due to the
use of an excessive amount of dye (three injections of 1% trypan
blue).
Behnsen’s paper of 1927 is longer and more detailed and the
results and interpretations differ in some respects to the 1926
paper. He speaks more cautiously about an increasing sealing of
the barrier during postnatal development and points out that
even in adult mice staining can be found in the brain due to local
penetration of dye. He commented: “The sites of dye penetration
in the adult animals correspond to the maximal storage in young
mice. They are located 1. In the region of Retzius’ependymal wedge
in the medulla oblongata; 2. At the attachment sites of the choroid
plexus; 3. In the infundibular recess” (Translation of orig.: “Die
Farbstoffdurchtrittstellen der erwachsenen Tiere entsprechen den
Speicherungsmaxima der jungen Mäuse. . . ”).
Behnsen (1927) himself does not appear to state unequivocally
that the barrier is immature in the newborn and his experi-
ments have a number of curious features. As was the case for
many barrier studies in the early part of the 20th Century, they
involved multiple injections of trypan blue into postnatal (2–3
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week old) and adult mice. He reported that areas of the brain
that stain for trypan blue at postnatal ages were more extensive
than in the adult, but they are located at the same sites, which
Behnsen calls “Grenzflächen” i.e., interfaces/membranes between
brain and bloodstream or even more generally used by Behnsen:
membranes involved in barrier functions are of the same struc-
ture in young and adult animals, they only differ gradually in their
function. “Die Übereinstimmung der Speicherstellen der erwach-
senen Tiere mit denen der jungen macht es sehr wahrscheinlich,
daß die Grenzflächen im erwachsenen Zustand, nur gradu-
ell verschieden, dieselben örtlichen Bauunterschiede aufweisen,
wie sie das Speicherbild für junge Tiere offenbarte.” (Behnsen,
1927, p. 570): The identical storage sites (of dye) in adult ani-
mals and in young ones makes it highly likely that the interfaces
(“Grenzflächen”) in the adult condition differ only gradually, but
are otherwise of the same structure as revealed by the dye storage of
young animals.
This is illustrated in two figures reproduced here in Figure 3.
The distribution of trypan blue is illustrated in sagittal sections
of mouse brain from the two ages. However, it is the same line
drawing of an adult brain that is used for both ages. This gives
the misleading impression that the distribution of the dye in
the postnatal brain was wider than it probably was in the actual
microscopical slides. This is because the neonatal brain is less
well developed particularly with respect to the neocortex. It is
also notable that there is no staining indicated in the postna-
tal neocortex as this is the region with the least well developed
vasculature in the postnatal period compared to the rest of the
brain; were the blood-brain barrier to dye to be immature, this
is precisely where dye staining would be expected to be appar-
ent. Bakay (1956) commented that although Behnsen’s conclu-
sions are frequently misquoted “they do not reveal a generalized
increase in permeability of the barrier.”
Behnsen’s experiments were repeated in careful detail by Moos
and Møllgård (1993). They studied the distribution of trypan
blue and Evans blue, a dye that superseded trypan blue from
about mid-20th century for blood-brain barrier studies. Moos
and Møllgård (1993) used a range of concentrations of the dyes
some of which exceeded the binding capacity of plasma albu-
min to which these dyes bind. Binding of dyes to plasma albumin
appears to have been overlooked by the blood-brain barrier field
until the observations of Tschirgi (1950), although Ehrlich him-
self commented that the lack of some of his small molecular
weight dyes in urine, was probably accounted for by binding to
plasma albumin (Ehrlich, 1885). Also, Stern and colleagues (e.g.,
Stern et al., 1929) made a distinction in guinea pig embryos and
neonatal animals of various species between the blood-brain bar-
rier permeability of low molecular weight sodium ferrocyanide
and the lack of penetration of trypan blue, which they described
as a colloid. Whether this description reflects knowledge of pro-
tein binding or aggregation of the dye in blood is not clear.
However, the difference between entry of small lipid insoluble
molecules (sodium ferrocyanide in early qualitative experiments
and sucrose and inulin in later quantitative experiments) and the
lack of entry of trypan blue turned out to be a fundamental dis-
tinction in properties of blood-brain and blood-CSF barriers, as
will be described below.
Stern et al. (1924) studied the entry of sodium ferrocyanide
from blood into CSF in various species at different stages of
development. They reported that in the guinea pig the barrier
to this molecule was already as in the adult, but in species born
at a less mature stage of development (rats, mice, cats) sodium
ferrocyanide could be detected in the CSF. Stern and Peyrot
(1927) extended the earlier study of Stern et al. (1924) examin-
ing entry sodium ferrocyanide into the CSF. In guinea pig fetuses
this marker did enter the CSF, but as reported earlier not in the
newborn of this species. They confirmed the entry of sodium fer-
rocyanide in the newborns of rats, mice and cats and in addition
rabbits.
Stern and Rapoport (1928a) studied the injection of dyes (try-
pan blue and Congo red) in neonates of various species. They
distinguished clearly between a barrier at the level of the vascu-
lar endothelium and the choroid plexus epithelium in dye studies
where cellular staining following dye injections, but unlike other
authors they thought this was a post mortem phenomenon. In a
following year using the same dyes Stern et al. (1929) made the
important point that it was necessary to limit the amount dye
injected. They stressed that in experiments in adults and devel-
oping animals using similar amounts of dye, no dye entered the
CSF. But if the amounts were increased substantially (30–40 times
than used normally) then staining of the CSF occurred.
Another dye study that is sometimes cited as evidence of bar-
rier immaturity in neonates (e.g., Ribatti et al., 2006) is that of
Penta (1932). Penta injected multiple doses of trypan blue or
trypan red into postnatal rabbits and cats. Penta seems to have
considered that the results of Behnsen and Stern were similar,
although as described above Stern et al. (1929) found no entry
of trypan blue in the brains of developing animals providing not
toomuch dye was injected. Penta summarized his results as show-
ing that the nervous system of neonates is colored more intensely
than that of adults and staining occurred in the regions where the
mesenchyme penetrates into the neuraxis. As in many of the adult
studies using trypan blue and against the advice of Stern (Stern
et al., 1929) Penta mainly used multiple large doses of trypan blue
and many of the animals died from the toxic effects of the dye;
therefore staining of the brain was hardly surprising. However,
Penta did describe one experiment in which much less dye was
used in which no staining of the brain (apart from the choroid
plexus) occurred, thus confirming Stern’s results, without Penta
apparently realizing it.
There seems little doubt that at least part of the problem with
many early dye studies, both in developing animals and adults,
was that the large amounts and multiple injections used led to
toxic effects. This might be indicative of a greater fragility of brain
barriers in immature animals but should not be interpreted as
evidence of an immature or absent blood brain barrier.
The binding of dyes to albumin in plasma was investigated sys-
tematically by Moos and Møllgård (1993). They showed that dye
only entered the brains of neonatal (one day old) mice and rats
if the albumin binding capacity was exceeded, except in regions
of the brain known to be devoid of a blood-brain barrier. For
concentrations of dye (trypan blue, 1–2%; Evans blue, 0.5–1.0%)
that were shown not to exceed the binding capacity of albumin
in plasma, neither dye penetrated into the brain by exudation
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FIGURE 3 | Behnsen’s much cited trypan blue experiments. (A) Brain from
postnatal mouse injected systemically 3 times with trypan blue at P4–P14.
(B) Adult mouse brain following systemic injection of trypan blue. Note that
as described by Behnsen the dye staining in the postnatal brain is in the same
regions as in the adult brain, but more extensive. This is probably a visual
artifact due to the use of an outline of an adult mouse brain for both ages. In
postnatal mouse brain (P14) the cerebral cortex and cerebellum are less
developed than illustrated here. Note also that in the postnatal brain there
does not appear to be any dye staining of the neocortex-the region of the
developing brain with the least mature blood vessels. From Behnsen (1927).
across cerebral vessel walls in either P10 or adult mice, although
there was some staining of choroid plexus epithelial and cere-
bral endothelial cells. At higher concentrations of the dyes (trypan
blue, 2–4%; Evans blue, 2%) at which there was a substantial level
of free dye, 60% of neonates and 20% of adults died, with higher
proportions at the higher concentrations of dye. Those animals
that survived showed various signs of neurotoxicity. Toxic effects
of trypan blue had been reported earlier (e.g., Behnsen, 1927;
Penta, 1932) but the significance of this in interpretation of bar-
rier studies with dyes seems to have been overlooked by all but
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Stern who urged caution in the amount of dye to be injected into
neonatal animals (Stern et al., 1929).
LATER STUDIES OF DYES, ALBUMIN AND OTHER MARKERS
IN IMMATURE ANIMALS
The use of dyes to study blood-brain barrier permeability in
immature animals began to die out in the second half of the 20th
Century. This is in contrast to the adult blood-brain barrier field,
which continues to place a heavy reliance on dyes, particularly
Evans blue, for assessing blood-brain barrier integrity. All of the
studies published after 1950 agreed in showing that dyes (usu-
ally trypan blue) did not enter the developing brain no matter
what age was investigated. The most important of these stud-
ies is probably that of Gröntoft (1954) who did experiments in
both human fetuses (recent abortions) and newborns. Gröntoft
emphasized that the condition of the fetuses was very important
in determining whether or not the dye entered the brain. In a
series of carefully conducted experiments he showed clearly that
when trypan blue was injected as soon as possible after separation
of the placenta in human fetuses of a wide range of gestational
age, the dye did not stain the brain as a whole, but only those
areas (choroid plexus and circumventricular organs) that are out-
side the blood-brain barrier (Figure 4); this was the case even in a
very immature embryo of 5 cm in length (approximately 10 weeks
post conception). However, when the dye was injected at pro-
gressively longer intervals after placental separation of the fetuses
(10–30min depending upon the gestational age) then the whole
of the brain stained. Gröntoft carried out similar well-controlled
experiments in rabbit fetuses with the same findings.
Grazer and Clemente (1957) injected by various routes solu-
tions of trypan blue into rat embryos from E10.5 to birth. They
found no evidence of dye penetration into the brain. Millen and
Hess (1958) injected i.p. two doses, 24 h apart, of either trypan
blue or sodium ferrocyanide, into neonatal (P0–P8) and adult
rats and the animals were examined after 30min. No staining of
the brain for either marker was identified in the neonatal animals
apart from the restricted regions (outside the blood-brain bar-
rier) that also stained in the adult. Similar results were reported
by Olsson et al. (1968) who injected fluorescently labeled bovine
albumin intravascularly in rat embryos as early as E15, compared
with neonates and adults.
In the second half of the 20th Century there was a switch from
using dyes to using horseradish peroxidase (HRP) as a test of
barrier integrity in the developing brain. HRP has a number of
problems that are not always well recognized by those that use
it. In the context of development the main problem is that, as
FIGURE 4 | Gröntoft’s dye experiments with postmortem aborted human
fetuses. (A) Human fetuses (14 cm-18 weeks to 30 cm-31 weeks gestation)
injected with trypan blue solution 30min after caesarian section delivery. (B)
Human fetuses (14 cm-18 weeks to 30 cm-31 weeks gestation) injected with
trypan blue solution 10min after caesarian section delivery. Note that for the
shorter period of anoxia none of the brains stained with trypan blue indicating
intact blood-brain barrier to trypan blue even in immature human fetuses.
Reproduced with permission from Gröntoft (1954), © Wiley.
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with the dyes in earlier experiments, too large a volume or con-
centration of HRP was injected, thus damaging fragile cerebral
blood vessels and giving the appearance of a “leaky” blood-brain
barrier (see Table 1). Several other authors reported the entry of
HRP into brains of very immature embryos, for example chick
embryos (Delorme et al., 1970; Delorme, 1972; Bertossi et al.,
1992). However, insufficient detail of exactly what was injected
makes it difficult to evaluate the results of these studies. The find-
ing that HRP entered the brain at different embryonic ages in the
same species or at different stages of brain development in dif-
ferent species suggests that the findings from these studies are
likely to have been artefactual. There have been a few reports of
Table 1 | Injection experiments used as test of blood-brain barrier integrity in fetal and neonatal animals.
Authors Species Age Body Injection volb Increase in plasma “Leaky” barrier Injected
(days) weight (g)a (% total blood vol) protein concentrationc claimed• materiald
Grazer and
Clemente, 1957
Rat E10.5 <0.06 Not stated – No Trypan blue i.p./i.v.b
Olsson et al., 1968 Rat E15 0.14 <5% – No Fluorescein-
albumin, Umb.A.
Delorme et al.,
1970
Chick E4.5 0.1 Not stated 3% Reaction product in
neuropil ECS until
E10
HRP i.v.
Wakai and
Hirokawa, 1978,
1981
Chick E8 0.5 10% 500% Yes HRP i.v.
Dziegielewska
et al., 1979, 1980
Sheep E60 60 7.5% 20% No Human plasma
protein i.v.
Lossinsky et al.,
1986
Mouse Newborn 1.4 35% 2% Yes, “massive
leakage”
HRP i.v.
Roncali et al., 1986 Chick E6 0.34 >150% 50% “Unimpeded
extravasation”
HRP intracardiace
Risau et al., 1986 Mouse E13 0.08 250% 1% increase “Fully permeable” HRP intracardiace
Vorbrodt et al.,
1986
Mouse Newborn 1.4 100% 200–300% Yes** HRP i.v.
Stewart and
Hayakawa, 1987
Mouse E15 0.26 Not stated 100%* Yes HRP i.p.f
Dziegielewska
et al., 1988
Tammar
wallaby
Newborn 0.50 10–20% 25–50% No HRP/HSA i.v.
Hulsebosch and
Fabian, 1989
Rat Newborn 5.0 50%* >400%* IgG penetration
into neuraxis
IgG i.p.b
Dermietzel et al.,
1992
Rat E14.5 0.14 100–150% >100% Yes HRP or 40 kDa
dextran
intracardiacd
Ribatti et al., 1993 Chick E6 0.36a >150% 50% “Massive
diffusion”
HRP or Evans blue,
intracardiac
Xu and Ling, 1994 Rat Newborn 5.0 10% 65% Yes Ferritin solution i.v.
Knott et al., 1997 Opossum P3 0.20 8%* 0.5%* No Human albumin i.p.
aBody weights and circulating blood and plasma volumes for chick embryos from Romanoff (1967) and Davis and Garrison (1968). Body weights of fetal rats from
unpublished data. Body weights of opossum from Saunders et al. (1989) and unpublished. Weight of youngest animal given.
bThe authors’ injection volume when stated has been compared to estimates of circulating blood volume (10% of body weight and allowing a factor of 2 for
placental blood volume in the case of fetuses and for extra-embryonic blood volume in chick embryos, although it is doubtful if under the conditions of some of
these experiments, much mixing with fetal placental blood would have occurred.
cThe actual circulating blood volume in sheep fetuses has been measured (Dziegielewska et al., 1991). The effect of the amount of injected protein on the
plasma protein concentration is also estimated when sufficient information is available. Plasma protein concentrations from Birge et al. (1974, chick embryo) and
Dziegielewska et al. (1981, rat fetus).
d Information is not usually available about the speed of injection nor about the likely distribution volume (e.g., in experiments involving intracardiac injection.
e In which the normal circulation may not have continued or i.p. injection.
f In which it is not clear what proportion of the volume and protein will have entered the circulation).
Youngest age studied. E is embryonic age from day of conception.
*Depending on proportion entering circulation. **But “not detected at E19.”
•Not all authors of experiments in which marker entered brain tissue from blood vessels describe this as a “leak” or due to immaturity.
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transendothelial passage of markers such as HRP in developing
brain (e.g., in tubulovesicular structures, Lossinsky et al., 1986)
whichmay explain the entry of themarker into immature brain in
some experiments, as lack of pinocytotic vesicles is a characteristic
of adult cerebral endothelial cells.
ENTRY OF SMALL MOLECULAR COMPOUNDS INTO THE
BRAIN AND CSF OF IMMATURE ANIMALS
Lina Stern and her colleagues published a preliminary report
of studies in a range of species of developing animals (Stern
et al., 1924). This was followed by a series of brief papers in the
period 1927–1929 on the permeability of the “barrière hémato-
encéphalique” to sodium ferrocyanide and several other low
molecular weight compounds in fetal guinea pigs and newborns
of several species (Stern and Peyrot, 1927; Stern and Rapoport,
1928a,b; Stern et al., 1929). Following injection into fetuses via the
uterine horn of pregnant guinea pigs early in gestation, sodium
ferrocyanide could be demonstrated by the Prussian blue reaction
in the CSF and CNS tissue. However, when sodium ferrocyanide
was injected into term embryo or newborn guinea pigs its pres-
ence could not be detected in either CSF or CNS tissue. In con-
trast, when sodium ferrocyanide was injected into the newborns
of rabbits, rats, mice, dogs, and cats it could be demonstrated
in CSF and nervous system tissue and for several days into the
neonatal period. Stern and Peyrot (1927) correlated the cessation
of sodium ferrocyanide entry into CSF and nervous tissue with
the time of eye opening and suggested that this was the time when
the blood-brain barrier (“barrière hémato-encéphalique”) to cer-
tain substances reached a “normal value,” presumably meaning
that it reached the adult condition. They concluded that in species
born at less mature stages of development (which they suggested
probably included human newborns) the “activity” of the bar-
rier was insufficient to protect the CNS against many substances
circulating or introduced into the blood.
These qualitative observational results with a small molecule
(sodium ferrocyanide 304Da) foreshadowed quantitative exper-
iments with radiolabelled small molecules such as mannitol
(182Da), sucrose (342Da), and inulin (5200Da) in newborns
of rats (Ferguson and Woodbury, 1969; Woodbury et al., 1974;
Johanson, 1989; Habgood et al., 1993) and fetal sheep (Evans
et al., 1974; Dziegielewska et al., 1979), which showed higher
CSF/plasma and brain/plasma ratios for the these molecules in
immature animals. Although initially interpreted as indicating
greater permeability of the blood-brain and blood CSF barri-
ers, it became apparent from measurements of CSF secretion in
embryos (Evans et al., 1974; Fossan et al., 1985) and newborns
(Bass and Lundborg, 1973; Johanson and Woodbury, 1974) and
increase in volume of CSF in rat embryos (Johansson et al., 2006,
2008) that the explanation is more likely to be that themuch lower
turnover (sink effect) of CSF in the developing brain allowed
a greater accumulation of marker in CSF and brain (Bass and
Lundborg, 1973; Johansson et al., 2008). However, it took the
development of the use of small molecular weight markers that
could be both quantified and visualized at the electron micro-
scopic, EM level to show that the route of penetration from blood
to CSF of these small markers was via an intracellular route in a
subpopulation of epithelial cells in the choroid plexuses (Ek et al.,
2001, 2003, 2006). These cells appear to be responsible for the
transfer of inert dextrans and several plasma proteins from blood
into CSF both in the developing and adult brain (Dziegielewska
et al., 1991; Liddelow et al., 2009, 2011a). The absolute number
of cells involved in this transfer actually increases with age as the
choroid plexuses develop, but the CSF/plasma ratios for dextrans
and proteins fall, because of the increased turnover of CSF and
a larger space into which these markers are diluted (Johansson
et al., 2006, 2008).
KERNICTERUS IN THE NEWBORN
One of the persistent beliefs about the blood-brain barrier in
the immature organism is that the toxic effects of unconjugated
bilirubin that accumulate in the blood of newborn infants suffer-
ing from erythroblastosis, generally due to Rhesus blood group
incompatibility, are due to “immaturity” of the blood-brain bar-
rier in the newborn. This is a suggestion generally attributed
to Spatz (1934) e.g., Broman (1941); Davson (1967), and Lee
(1971). Others stated that this was the case but without attri-
bution (e.g., Ganong, 1993; Cotran et al., 1994). Bakay (1956)
expressed the view that “the phenomenon of kernicterus appeared
to offer irrefutable proof of this theory [that the blood-brain bar-
rier in the newborn is immature].” In his later review Bakay is
more circumspect and suggests that the causation of kernicterus
has many components of which an immature blood-brain barrier
might be one (Bakay, 1968).
Most of Spatz’s lengthy paper is taken up with describing
and repeating some of Behnsen’s (1927) experiments with trypan
blue. But he does have a short section on icterus (jaundice) in the
adult, with an illustration showing that yellow pigment of biliru-
bin was confined to dura. He compared this (without illustration)
to brain damage (kernicterus) that only occurs in the newborn
with the deposition of bilirubin in the brain, characteristically in
the basal ganglia and brain stem (Figure 5). He does not seem
to distinguish between conjugated bilirubin, which accumulates
in the circulation of adults sometimes to very high levels, and
unconjugated bilirubin that accumulates in newborns because the
activity of the conjugating liver enzyme, glucuronyl transferase,
is very low at birth and normally increases during the first days
of life. These two forms of bilirubin had been identified earlier
(van den Bergh and Müller, 1916). What was not known in the
1930s was that unconjugated bilirubin binds tightly to plasma
albumin and a key factor (but not the only one) in the occur-
rence of kernicterus is when the binding capacity of albumin for
unconjugated bilirubin is exceeded; this form of bilirubin which
is highly lipid soluble (in contrast to conjugated bilirubin) enters
the brain without restraint.
It is noteworthy that clinicians, who have had to deal with the
problem of kernicterus in the newborn for many years, rarely
seem to have invoked the state of maturity of the blood-brain
barrier in the neonate as a major factor in the occurrence of ker-
nicterus (e.g., Iskander et al., 2014), although it has occasionally
been mentioned (e.g., Zuelzer and Mudgett, 1950; Spiegel-Adolf
et al., 1954; Ernster et al., 1957); rather they developed clinical
treatments aimed at reducing the level of unconjugated biliru-
bin in infants who were at risk: exchange transfusion (Allen
et al., 1950; Gerrard, 1952) barbiturate induction of glucuronyl
www.frontiersin.org December 2014 | Volume 8 | Article 404 | 11
Saunders et al. History of blood-brain barrier concepts and misconceptions
FIGURE 5 | Kernicterus in brain of neonatal monkey with jaundice. Note staining of putamen (one of the basal ganglia), which does not occur in adult brain
as jaundice in adults, is generally due to high levels of conjugated bilirubin to which the blood brain barrier is impermeable. From Windle (1969).
transferase and phototherapy (Lucey, 1971) as well as prevention
by immunization of Rh-ve women against the D blood group
antigen (Clarke, 1989). But the linking of blood-brain barrier
immaturity to kernicterus has persisted amongst other groups of
scientists and clinicians for decades after Spatz (1934). A good
example is a physiologist, (Ganong, 1993) who stated that: “Bile
pigments do not enter the brain in the adult but in the fetus
and newborn infant the blood-brain barrier is not developed.”
Following correspondence with one author (NRS) in later edi-
tions Ganong (1999) modified this to state that “the bilirubin
penetrates the brain of infants with erythroblastosis at least in part
because the blood-brain barrier is more permeable in infancy”;
he was not willing to take account of the effect of binding of
unconjugated bilirubin to plasma albumin. Similar wording has
been retained by the new authors of Ganong’s Review of Medical
Physiology (Barrett et al., 2012) following his unfortunate demise.
Some aspects of bilirubin neural toxicity are discussed by Palmela
et al. (submitted).
Some pathologists have also considered that kernicterus is due
to immaturity of the blood-brain barrier (Cotran et al., 1994).
A detailed consideration of kernicterus is beyond the scope of
this review. But comprehensive papers are available both on the
pathogenesis and treatment particularly by Wennberg and his
colleagues (e.g., Wennberg, 2000; Ahlfors and Wennberg, 2004;
Wennberg et al., 2006) and in Volpe (2008). However, it is becom-
ing increasingly clear that the mechanisms involved in whether
or not kernicterus occurs in newborns are much more complex
than the absolute level of unconjugated bilirubin and the bind-
ing capacity of albumin in plasma. These complexities have been
reviewed by Ghersi-Egea et al. (2009) and include the finding
that bilirubin is a substrate for several ABC efflux transporters,
which would thus be expected to contribute to limiting the entry
of bilirubin into the brain.
EXPERIMENTS WITH RADIOISOTOPICALLY LABELED
MOLECULES IN DEVELOPING ANIMALS
The introduction of radiolabelled markers was a major advance
in experimental approaches to understanding blood-brain bar-
rier mechanisms. The use of inert markers of permeability such
as sucrose and inulin has been mentioned above. In this sec-
tion we shall deal briefly with experiments involving the use of
P32 and amino acids labeled with 3H or 14C. Compared to inert
markers there are potential problems with metabolically active
radiolabelled molecules such as amino acids. Thus it needs to be
Frontiers in Neuroscience | Neurogenomics December 2014 | Volume 8 | Article 404 | 12
Saunders et al. History of blood-brain barrier concepts and misconceptions
shown that the radioactive tag is still attached to the molecule
and that the measured radioactivity is due to transfer into the
brain separate from its metabolic incorporation, for example into
proteins.
32PHOSPHORUS
Bakay (1953, 1956) studied the uptake of 32P into brain and
other organs following parenteral injection into pregnant (3rd–
4th week), newborn, up to 7 weeks postnatal rabbits and in the
adult. Animals were killed 24 h after injection and various organs
dissected out. In some cases radioautographs of the heads or
brains of fetuses were prepared. The results showed amuch higher
uptake of 32P in the younger the animals. In fetuses and new-
borns the brain/blood ratio was >1, compared to about 0.3 in
the adult, which Bakay (1953) interpreted as indicating that the
vascular permeability in the fetal brain is increased. He discusses
whether the increased permeability reflects a leaky, incompletely
formed blood-brain barrier or increased metabolism and faster
turnover in the developing nervous system. He concluded that
neither explanation was satisfactory. Bakay (1953) observed that
in the radioautographs of fetal brain the distribution of 32P was
almost uniform whereas in the brain of the mother it was con-
centrated in the choroid plexuses and the lining of the ventricles.
Rather puzzlingly he took this as evidence that there is a blood-
brain barrier to 32P in the fetus but that its permeability is greater
than in the adult.
AMINO ACID TRANSPORT
In early experiments with radiolabelled amino acids there was a
similar finding of a much greater entry of some (but not all) into
the developing than adult brain of several species (Himwich et al.,
1957; Roberts et al., 1959; Purpura and Carmichael, 1960; Lajtha
and Toth, 1961; Seta et al., 1972; Baños et al., 1978) but as with
32P it was not possible to distinguish between cerebral endothe-
lial cell transport and metabolic incorporation into brain tissue
in accounting for the greater uptake in developing brain. Some
authors interpreted such results as indicating “lesser effective-
ness” of the blood-brain barrier for amino acids in young animals
(e.g., Kuttner et al., 1961; Lee, 1971). The problem of deter-
mining cerebral transport of amino acids across the blood-brain
barrier without the complication of metabolic contamination
of brain samples was solved by Oldendorf (1971) who devel-
oped a short pass technique in which exposure of amino acid or
other metabolically active molecules to the brain from the cere-
brovascular circulating blood was limited to one circulation time,
thus being too quick for significant metabolic incorporation to
occur. The technique was adapted for newborn and postnatal
animals by Oldendorf ’s students (Braun et al., 1980; Cornford
et al., 1982; Pardridge andMietus, 1982) and by Lefauconnier and
Trouvé (1983), Al-Sarraf (2002), and Al-Sarraf et al. (1997). These
experiments showed that many amino acids and other metabol-
ically active compounds were transported into developing brain
at much higher rates than in the adult; this was interpreted as
reflecting the greater metabolic demand of the developing brain
rather than immaturity of the blood-brain barrier. However,
some authors have continued to suggest that greater uptake may
reflect barrier immaturity (e.g., Watson et al., 2006).
Thus it has been clear for sometime that transport mechanisms
at the brain barrier interfaces determine the composition of the
internal environment of developing brain and supply essential
nutrients and other molecules important for growth and differ-
entiation of the brain. What has been lacking until recently is
information on the presence and expression of specific trans-
porters in the brain barrier interfaces. This is now available
from expression studies of isolated cerebral endothelial cells from
neonatal mice (Daneman et al., 2010a) and from choroid plexuses
of fetal mice and rats compared to the adult (Liddelow et al., 2012,
submitted). Many of these so called Slc transporters are expressed
at higher levels in the developing brain compared to the adult,
thus accounting for the earlier observations of higher entry of
specific amino acids into the developing brain. There are differ-
ences in the expression patterns of these Slc transporters in the
cerebral endothelial cells and in the choroid plexus epithelial cells
and many more are expressed at higher levels in the fetal choroid
plexus (see reviews by Saunders et al., 2013 and Liddelow et al.,
submitted). This reflects the greater importance of the choroid
plexuses for transport into the brain compared to the vasculature
at very early stages of brain development. The plexuses develop
much earlier than the blood supply (Johansson et al., 2008). The
findings also help to explain a number of important observa-
tions on developmentally different effects of amino acids on brain
function. For example it was reported many years ago that gluta-
mate is toxic to the brain if administered in the neonatal period
(Olney and Ho, 1970) which some attributed to “immaturity” of
the blood-brain barrier (Viña et al., 1997). However, it can now be
seen that the barrier contribution to toxicity is much more likely
to be due to greater transport of glutamate by e.g., Slc1a4 (see
Saunders et al., 2012).
THE PARACELLULAR PATHWAY AND TIGHT JUNCTIONS IN
BARRIER INTERFACES IN THE DEVELOPING BRAIN
The concept of the paracellular pathway is an important tenet of
epithelial biology that was extended to cerebral endothelial inter-
faces. It arose from some ingenious experiments of Frömter and
Diamond (1972). These authors measured transepithelial resis-
tance in a variety of epithelia in vitro by passing a microelectrode
over the external surface of the epithelium. They observed that
when the electrode tip was over the region of the border between
adjacent cells there was a marked drop in resistance across the
epithelium. Frömter and Diamond proposed that this indicated
a low resistance pathway across the epithelium for water and
ion flow. They subsequently extended this concept to include the
paracellular pathway as the route by which small lipid insolu-
ble molecules such as sucrose crossed epithelia (Diamond, 1974).
The physical basis for the paracellular pathway is the junctional
complex between adjacent cells and in particular the tight junc-
tion component of the complex (Brightman and Reese, 1969).
However, there are some important limitations to this interpre-
tation of the sites of low resistance across epithelia. Firstly the
dimensions of the tip of the microelectrodes used by Frömter and
Diamond was about 5µM compared to the intercellular space at
the level of tight junctions, which is measured in nanometers, if
not zero where adjacent cell membranes are fused. Thus an alter-
native explanation for the low resistance pathway is that there is
www.frontiersin.org December 2014 | Volume 8 | Article 404 | 13
Saunders et al. History of blood-brain barrier concepts and misconceptions
an intracellular pathway close to the border of the cell membrane
between adjacent cells.
Diamond (1974) seems to have acknowledged this possibility
as he suggested that in some epithelia the low resistance pathway
might be due to “leaky” cells, although he thought this would
be exceptional. Secondly, water and ions cannot yet be visual-
ized with sufficient resolution for their route across epithelia to
be defined. Until recently this was also the case for low molecu-
lar weight compounds such as sucrose and inulin; however, this
problem has been solved by the use of biotin labeled small molec-
ular sized compounds that can be visualized at both the light and
electron microscopical level. At least in the case of choroid plexus
epithelial and cerebral endothelial cells in the South American
opossum, Monodelphis domestica, the intercellular junctions are
impermeable to a compound biotin ethylenediamine that is
smaller than sucrose (Ek et al., 2001, 2003, 2006). In addition it
was found that biotin labeled markers transfer across a subpopu-
lation of plexus epithelial cells and not between them (Ek et al.,
2001, 2003, 2006; Liddelow et al., 2009). These studies require
independent replication, preferably in several different species,
but they indicate that the earliest vessels growing into the brain
are structurally well enough developed for their tight junctions
to be impermeable to even very small molecules. These results
also suggest that the presence of a low resistance pathway across
epithelial cells, rather than the paracellular route, as envisaged by
Diamond (1974) as an exceptional situation may indeed exist.
Over many years the results of ultrastructural studies of tight
junctions in the cerebral vasculature and choroid plexuses of the
developing brain have been conflicting. Two of the earliest ultra-
structural studies of the developing mammalian brain barriers
were those of Donahue and Pappas, (1961, rat cerebral capillaries)
and Tennyson and Pappas (1964, rabbit choroid plexus). Most of
their descriptions dealt with subcellular structures, but they do
comment on and illustrate what in those days were called termi-
nal bars that were present in the earliest embryos examined (E14).
These appear to correspond to structures associated with what
were subsequently described as tight junctions (Brightman and
Reese, 1969). Particularly considering that the 1960s were early
days for electron microscopy of developing brain tissue (which
in those days was regarded as very difficult to fix adequately) the
micrographs of Donahue and Pappas and Tennyson and Pappas
are of high quality and show clearly well formed intercellular
tight junctions. Tennyson (1975) published a more comprehen-
sive paper on choroid plexus development in human and rabbit
fetuses. It includes illustrations of what she now refers to as “tight
junctions” in the earliest rabbit fetuses studied (E15).
Subsequent to the early paper of Tennyson and Pappas (1964)
there have been numerous transmission electron microscope
studies of tight junctions in the developing brain, mainly in chick
embryos (Delorme et al., 1970; Delorme, 1972; Roy et al., 1974)
rodents (Stewart and Hayakawa, 1994) fetal sheep (Møllgård and
Saunders, 1975, 1977; Møllgård et al., 1976, 1979) but also some
in human fetuses (Møllgård and Saunders, 1975, 1986; Virgintino
et al., 2004). Most, but not all, seem to agree that the typi-
cal appearance of closely apposed cell membranes of adjacent
cerebral endothelial cells appears very early in brain develop-
ment, although some authors (e.g., Stewart and Wiley, 1981)
nonetheless conclude that the blood-brain barrier at these early
stages is more permeable than in the adult. This was based
on citing papers showing greater entry of both metabolically
active and inert molecules into the developing brain and a high
concentration of protein in CSF (cf. Sections 6, 8, and 11).
Some authors also used HRP in an attempt to delineate the
age at which there was a change from blood-brain barrier perme-
ability to one of impermeability. However, insofar as the method-
ological information is available it seems likely that in many
experiments excessive volumes or concentrations of HRP solu-
tion or other markers were injected, thus mechanically disrupting
the fragile blood vessels (e.g., Wakai and Hirokawa, 1978, 1981;
Risau et al., 1986; Stewart and Hayakawa, 1987; Bertossi et al.,
1988; Ribatti et al., 1993; and see Table 1). Also HRP has toxic
effects and may give rise to anomalous permeability results, even
in adult animals (e.g., Mazariegos et al., 1984). Nevertheless Tauc
et al. (1984) were able to show that tight junctions in the choroid
plexuses of rat embryos at least as early as E14 were imperme-
able to HRP. These observations were supported by freeze fracture
studies showing a similarly early development of tight junction
structure.
Møllgård et al. (1976) carried out a quantitative study of
freeze fracture tight junction complexity in fetal sheep embryonic
choroid plexus. This showed that there were only minor changes
in junctional complexity over a large period of development in
contrast to reports in the same species of large developmental
changes in apparent permeability from blood to CSF for small
molecular markers (Evans et al., 1974; Dziegielewska et al., 1979).
It should be noted that the large change in apparent permeability
was probably mainly due to an increase in CSF secretion rate (see
above), but this does not diminish the significance of the find-
ing that the freeze fracture appearance of choroid plexus tight
junctions appeared very early in development.
Dermietzel et al. (1977) published a detailed freeze fracture
study of the development of intercellular junctions of the chick
embryo choroid plexus from E5, the day on which it begins to
differentiate. A junctional network of strands was apparent by
E6 and by E9 intercellular zonula occludens were more or less
complete.
Attempts to correlate expression of individual tight junction
genes with some supposed age when cerebral blood vessels stop
being leaky, seem doomed to failure unless experiments are con-
ducted under adequate physiological conditions. The findings
that different tight junction genes are expressed at different ages
and that the junctions become molecularly more complex with
age seem more likely to reflect changes in the mechanical proper-
ties of tight junctions in the face of increasing hydrostatic pressure
(systemic blood pressure) during embryonic and fetal develop-
ment (Evans et al., 1974; Dziegielewska et al., 1979). The question
of whether or not there is a stage of early vascularization of the
brain when the blood vessels are leaky is a functional one that can
only be answered by permeability experiments conducted under
reasonably physiological conditions. In spite of several attempts
(e.g., Risau et al., 1986; Mizee et al., 2013; Ben-Zvi et al., 2014,
see also Bauer et al., 2014) there is no convincingly demonstrated
link between the expression of one particular gene and the sup-
posed sealing of blood vessels entering the CNS tissue, apart
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from Nitta et al. (2003) who showed increased permeability to
small molecules (<800Da) in claudin 5-deficient mice; this was
attributed to tight junction permeability although not confirmed
at the ultrastructural level.
IONIC GRADIENTS BETWEEN CSF AND PLASMA IN THE
DEVELOPING BRAIN
Some of the most convincing evidence that some critical brain
barrier properties develop very early in the embryo comes from
studies of ion gradients between CSF and plasma. In the adult
the ionic composition of CSF is characteristically different from
that of plasma and is also appreciably more stable. This reflects
the importance of a homeostatically constant environment that is
a prerequisite for normal brain function (Davson, 1967; Davson
and Segal, 1996). The gradients are set up by ion pumps in the
epithelial cells of the choroid plexuses (Damkier et al., 2013).
Similar pumps in the cerebral vascular endothelial cells may also
contribute via the extracellular fluid of the brain (Davson and
Segal, 1996). An essential structural component of this homeo-
static mechanism is the presence of tight junctions between the
adjacent cells of the choroid plexus epithelium and cerebrovas-
cular endothelium. Thus in development, if even a single ion
gradient is present, it indicates the presence of both a cellular ion
pump and functional integrity of the tight junctions, as without
the latter a gradient simply cannot be established. In the 1970s–
80s there were several studies in a variety of species showing
the presence of ion gradients between CSF and plasma (Flexner,
1938; Bito and Myers, 1970; Bradbury et al., 1972; Amtorp and
Sørensen, 1974; Sedlácek, 1975; Mitchell et al., 1982; Nattie et al.,
1984). More recently gene expression studies have shown that
key ion channel and transporter genes are expressed very early
embryonic life in the choroid plexuses (Liddelow et al., 2012,
2013).
CONCENTRATION AND ORIGIN OF PROTEINS IN CSF IN
DEVELOPING BRAIN
One of the pieces of evidence sometimes put forward in favor of
immaturity or leakiness of the blood-brain barrier in the develop-
ing brain is that the CSF in fetal and newborn animals contains a
much higher concentration of protein than in the adult (Adinolfi
et al., 1976; Adinolfi and Haddad, 1977; Ramey and Birge, 1979;
Adinolfi, 1985; Fishman, 1992). Strictly speaking the composition
of CSF is much more determined by movements of molecules
across the choroid plexuses rather than entry via the blood ves-
sels and brain interstitial fluid, although clinicians frequently (but
erroneously) interpret CSF changes as reflecting changes in per-
meability of the blood-brain barrier. Since the middle of the last
century it has been known that the concentration of protein in
human newborn CSF (e.g., Spiegel-Adolf et al., 1954; Nasralla
et al., 1958) is higher than in the adult (Davson and Segal, 1996)
and even more so if the infants are prematurely born (e.g., Otila,
1948; Bauer et al., 1965). Results from these and other studies
are summarized in Table 2. The mean values reported for healthy
term babies were in the range 63–115mg/100ml. For pre-term
infant the mean values in different series were generally higher
(up to nearly 190mg/100ml). Little information about human
fetal CSF is known but Adinolfi published important studies on
Table 2 | Total protein concentration (mg/100ml) in CSF of full term
and pre-term infants estimated during the first few days of life.
Authors Mean S.E.M Range n Condition
(mg/100ml)
FULL TERM
Spiegel-Adolf et al.,
1954
103 9.9 – 14 Normal
Widell, 1958 80.9 6.2 – 11 Healthy
Nasralla et al., 1958 115 5.8 46–194 34 Normal
Naidoo, 1968 63 1.6 32–240 135 Healthy
Piliero and Lending,
1959
70 6.0 25–90 35 Normal
Watson, 1964 77 5.3 26–180 51 Cerebral
anoxia
Heine et al., 1981a 73.0 17.6 53–95 10 No cereb
meningitis
Ahmed et al., 1996 80.8 30.8* – 17 Prev.
healthy
Chadwick et al.,
2011
106 – 94–115*** 54 No
meningitis
Srinivasan et al.,
2012
78ˆ 137** 60–100 130 Normal
PRE TERM
Otila, 1948b 100 5.5 50–138 19 Healthy
Nasralla et al.,
1958c
167 6.4 81–259 49 Normal
Gyllenswärd and
Malmström, 1962d
176 26 57–292 9 Healthy
Bauer et al., 1965e 187 28 30–1600 70 Various
Bartolozzi et al.,
1967f
62 4.3 12–144 59 Normal
Cole et al., 1974g 120 10 – 9 Normal
Sarff et al., 1976 90 – 20–170 No
meningitis
Statz and
Felgenhauer, 1983h
139 77* 68–240 10 No
pathology
Mhanna et al.,
2008i
180ˆ – 124–270 10 Suspect
sepsis
Srinivasan et al.,
2012j
104ˆ 203** 79–131 148 Normal
a0–4 weeks. No data on birth weights or gestational age.
bBirth weights 920-2150 g, Table 19, p. 91.
cBirth weights ≤ 4.5 lbs, Table 2, p. 1404.
d Birth weights ≤ 2000 g, Table 5, p. 60.
eBirth weights 800–2620 g, Figure 1, p. 1018.
f Birth weights ≤ 2500 g, Figure 2, p. 299.
gBirth weights 1080–1710 g, Table 1, p. 724.
h27–32 weeks, Table 3, p. 158.
i 27 weeks, values less at younger and older ages.
j 28–35 weeks, Tables II, p730 and III, p731.
*S.D. **95th percentile. ***CIs. ˆ Median.
CSF and plasma proteins obtained from aborted human fetuses
(Adinolfi et al., 1976; Adinolfi and Haddad, 1977; Adinolfi, 1985).
These studies showed that the concentration of total protein and
of individual proteins such as a-fetoprotein, transferrin and IgG
were much higher than reported for live-born infants; the highest
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individual total protein value reported was 730mg/100ml at 24
weeks gestation (Adinolfi et al., 1976) although it needs to be born
in mind that the CSF samples were obtained from aborted fetuses
of uncertain physiological state.
Similar results, however, have been obtained for numerous
animal species where it was possible to obtain CSF and plasma
samples from a wide range of stages of fetal and neonatal develop-
ment collected under good physiological conditions. The results
from animal studies have been reviewed by Saunders (1977, 1992)
and by Dziegielewska and Saunders (1988). One of the earli-
est studies was by Klosovskii (1963) in cat embryos in which
CSF protein concentration was up to 22 times that in the adult.
Klosovskii correctly interpreted this as having some nutritive
function in the developing brain rather than ascribing it to barrier
immaturity. The concentration of total protein and of individ-
ual proteins in fetal CSF is much higher than in the newborn
and adult, but if samples were obtained early enough in develop-
ment the level was lower than a peak that occurred in all species
probably coinciding with the period of maximum neurogene-
sis. Although Adinolfi (1985) and others interpreted the high
CSF concentration of protein in CSF in the developing brain as
evidence of a leaky blood-brain and/or blood-CSF barrier there
is now substantial evidence that it is a consequence of specific
transport of proteins from blood to CSF via a subpopulation of
choroid plexus epithelial cells (Dziegielewska et al., 1980, 1991;
Habgood et al., 1992; Knott et al., 1997; Johansson et al., 2006,
2008; Liddelow et al., 2009, 2011a,b). In addition it should be
noted that the concentration of protein in any space is a func-
tion of its amounts and volume in which they distribute. As has
been shown by Johansson et al. (2008) the amount of protein in
the adult CSF is actually greater in the fetus due to a combination
of expanding of the ventricular system and increased CSF flow.
INDUCTION OF TIGHT JUNCTIONS IN BRAIN BARRIER
INTERFACES
Another widespread misconception is that astrocytes are essential
for the induction of tight junctions in cerebral blood vessels in
the developing brain. In adult brain end feet of astrocytes encircle
cerebral capillaries (Caley andMaxwell, 1970; Xu and Ling, 1994).
They are thought tomake significant contributions to blood-brain
barrier functions (Abbott et al., 2006). The belief that astrocytes
may be involved in tight junction formation in the developing
brain seems to stemlargely from in vitroexperiments. Inculture the
presenceof eitherastrocytesorconditionedmediumfromcultured
astrocytes produced cells with more complex tight junctions
(Tao-Cheng et al., 1987) and was essential for the preparation
of cerebral endothelial monolayers with high transendothelial
resistance (Dehouck et al., 1990; Rubin et al., 1991). Janzer
and Raff (1987) are frequently cited as supporting the notion
that astrocytes are essential for tight junction formation in vivo.
However, Holash et al. (1993) showed their results were an artifact
(see Saunders et al., 2012, for further discussion). It seems to
have been overlooked that there are no astrocytes present in the
developing brain when it is first vascularized (Caley and Maxwell,
1970; Daneman et al., 2010a). As first shown by Stewart andWiley
(1981) using chick-quail chimeras, tight junction formation in
cerebral vessels is induced by some factor in the neural tissue of
the developing brain. The vessels are tight to proteins and small
molecules from as early as vessels first grow into the neural tissue
(Bauer et al., 1993, 1995; Ek et al., 2006). It is not yet clear what
the induction factor(s) is/are. However it seems that the pericytes
make an important contribution to tight junction formation
(Daneman et al., 2010b). The main period of differentiation of
astrocytes and their association with capillaries occur in rodents
in the first 3 weeks of postnatal life (Caley and Maxwell, 1970).
It may be that astrocytes contribute to tight junction-induction
during this period of intense vascularization, and subsequent
maintenance of tight junctions, but they are not involved in
earlier stages of vascularization of the brain.
WHY IS IT IMPORTANT TO UNDERSTAND FUNCTIONING OF
BARRIER MECHANISMS IN THE DEVELOPING BRAIN?
It seems unsatisfactory that this belief in the “immaturity” or
leakiness of the blood-brain barrier has persisted into the 21st
Century in spite of much evidence to the contrary as reviewed
above. There are two quite different reasons why it is important
to understand the functional status of barrier mechanisms in the
developing brain. The first is that they are likely to be important
for different features of brain development at different stages in its
development. This is suggested for example, by changes in gene
expression for different efflux and influx mechanisms in both
the cerebral vasculature and choroid plexuses during brain devel-
opment (Virgintino et al., 2000, 2007; Daneman et al., 2010a;
Liddelow et al., 2012; Kratzer et al., 2013).
The other reason is that it is clinically important. At present
because of a lack of information on the extent to which drugs
enter the developing brain of the embryo following adminis-
tration to the mother, the general advice given by doctors to
pregnant women is to avoid taking drugs. However, this is not
very helpful advice in the case of patients with severe medical con-
ditions requiring continued treatment such as epilepsy (Forsberg
and Wide, 2011) depression and anxiety (El Marroun et al., 2014;
Ornoy and Koren, 2014) psychosis (Galbally et al., 2014) can-
cer (van Hasselt et al., 2014), or severe hypertension (Brown and
Garovic, 2014).
In the US it has been estimated that between 30 and 35%
of women have taken psychoactive drugs during pregnancy
(Goldberg and Nissim, 1994). In a study of nearly 100,000 preg-
nancies, Andrade et al. (2004) found that 64% of pregnant
women received a drug prescription. In a four nation study in
Europe (De Vigan et al., 1999) an average of 36% of women
interviewed used at least one drug during the first trimester of
pregnancy. There was substantial national variation (22.5% in
Glasgow and 50 and 40% in two centers in France). Because
drugs are not systematically investigated for possible deleterious
effects on the developing brain the clinical management of preg-
nant women may be a difficult decision between what is best
for the mother and limiting potential damage to the developing
fetal brain. This lack of knowledge not only makes it difficult for
doctors to make rational decisions about when to and when not
to medicate, but commonly results in non-compliance to pre-
scribed medication, terminating medication or self-medication,
as well as alternative natural remedies being used by mothers
(Wood et al., 2014). The only information available to clinicians at
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present consists of collections of reports of adverse effects or lack
of such effects in compendia such as Yaffe’s index (Briggs et al.,
2008) or national data organizations such as the US Food and
Drug Administration (FDA) or the Australian Drug Evaluation
Committee in pregnancy, which classify drugs into categories
A/B/C/D/X, where A are drugs shown to be safe for the human
fetus and X known to induce birth defects (see Teratology Society
Public Affairs Committee, 1994). The majority of drugs fall into
categories B and C, drugs for which there are not enough data
in humans to know whether they are safe for the fetus. The con-
sequences of the currently inadequate state of knowledge about
the safety of medications administered during pregnancy have
been highlighted by Kennedy (2011). This classification has been
under sustained criticism from the Teratology Society in the US
(Teratology Society Public Affairs Committee, 1994, 2007) pri-
marily on the grounds that the lack of knowledge about drugs
used in pregnancy generates difficulties in making clinical deci-
sions and causing considerable anxiety in patients. This classi-
fication is now being abandoned in the US, in favor of a new
pregnancy and lactation-labeling rule designed to improve risk
versus benefit assessment of drugs used in pregnant and nursing
mothers (Ramoz and Patel-Shori, 2014).
Drug use during pregnancy is likely to increase in the future
due to higher average ages of mothers, increasing the likeli-
hood of pregnancy complications as well as a higher incidence
of premature births with significant medical interventions as a
consequence. There is also a growing apprehension that envi-
ronmental toxins may affect the developing brain. One review
listed over 200 industrial compounds known to be neurotoxic
in humans and experimental studies have shown over 1000 sub-
stances (Grandjean and Landrigan, 2006); this list probably only
represents a very small fraction of all chemicals that are neuro-
toxic. It is particularly inappropriate that public bodies such as
the Agency for Toxic Substances and Disease registry (ATSDR)
at the Centre for Disease Control in the US should perpetuate
statements about immaturity of the blood-brain barrier based on
out of date information and mythology. This has been discussed
in detail by Ek et al. (2012) but this discussion appears to have
had no impact on current reports published by the ATSDR. A
more hopeful sign is that the CDC has recently convened meet-
ings to discuss developing a more systematic approach to safer
medication use in pregnancy (Broussard et al., 2014).
Recent gene expression studies in developing animal brains
(Daneman et al., 2010a; Liddelow et al., 2012, submitted; Kratzer
et al., 2013) suggest that many of the protective efflux mechanism
that prevent entry of drugs and toxins into the adult brain are
present and in some cases more highly expressed in blood vessels
and choroid plexuses of the developing brain. However, expres-
sion does not necessarily equate with functional effectiveness, so
there is an urgent need for systematic drug studies in pregnant
and newborn animals and people, in order to define clearly the
potential hazards or lack of hazards, when drugs are administered
to pregnant women.
SUMMARY
In conclusion, it seems that many of the most strongly held beliefs
about the early history of the blood-brain barrier are incorrect.
The blood-brain barrier was not described first by Ehrlich (1885);
indeed he did not believe that there were any differences in perme-
ability of cerebral blood vessels compared to the rest of the body.
Lewandowsky (1900) did not coin the term blood-brain barrier
(“Blut-Hirnschranke”). The first person to use this term seems to
have been Stern (Stern and Gautier, 1921). Goldmann (1909) was
not the first person to demonstrate that some dyes (in his exper-
iments trypan blue) do not enter the brain following parenteral
injection. This appears to have been first reported by Franke
(1905) who used trypan red. Behnsen (1927) although frequently
cited as providing evidence for immaturity of the blood-brain
barrier did not do so. Other claims of barrier immaturity or
leakiness in developing animals in dye injection experiments can
be explained by use of excessive volumes or concentrations of
material injected into fragile animals. Early induction of tight
junctions in cerebral vessels does not involve astrocytes. At least
in the choroid plexus the route of transfer from blood to CSF is
intracellular and not via the paracellular pathway.
The importance of discarding the notion of blood-brain bar-
rier immaturity or leakiness in the developing brain lies in the
fact that this belief has impeded research into these mechanisms
in brain development and their possible relevance for normal
and abnormal brain development, as well as the need for system-
atic studies of therapeutic agents used to treat pregnant women.
Therapeutic advice to such patients should be based on evidence,
not fear of the unknown.
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BIOGRAPHIES
George BernaysWislocki (1892–1956)
1892 Born March 5th in San Jose California
1912 Graduated fromWashington University
1916 Graduated from The Johns Hopkins University School of
Medicine
1916–1917 Postdoc Assistant in Anatomy under Lewis H Weed
1916–1923 Served as First Lieutenant in U.S. ArmyMedical Corps
during WW1
Arthur Tracy Cabot Fellow at the Laboratory of Surgical
Research at Harvard University
Associate in Anatomy at Johns Hopkins
1923 Associate Professor of Anatomy at Harvard University
1931–1941 Parkman Professor of Anatomy at Harvard University
1931 Married Florence Clothier
1939–1940 Member scientific advisory board, Wistar Institute of
Anatomy and Biology
1941 James Stillman Professor of Comparative Anatomy at
Harvard University
1941 Elected to National Academy of Sciences
1941 Honorary Master of Arts degree, Harvard University
1947 Hersey Professor of Anatomy, Harvard Medical School
1950–1951 First President of the Histochemical Society
1951 Honorary Doctor of Science, Washington University
1956Died October 22nd in Milton, US (aged 64). Survived by his
wife Florence, 2 sons (George and Lewis) and 2 daughters (Edith
and Johanna)
Scientific contributions: Wislocki is considered one of the pio-
neers in the use of histochemistry in anatomical studies. He
greatly contributed to the description of the anatomy and func-
tion of the endocrine system as well as the comparative anatomy
of the placental and brain-barriers. He was the first to publish an
image of a dye experiment showing that dye (trypan blue) did not
enter the brain of a guinea pig fetus (Figure 1A) except in regions
known to have a barrier in the adult brain.
National Academy of Sciences (http://www.nasonline.org/
member-directory/deceased-members/20001486.html)
J. Histochem Cytochem. 1957 Jan;5(2):96. “GEORGE BERNAYS
WISLOCKI, 1892–1956”
The Harvard Crimson http://www.thecrimson.com/article/1956/
10/23/wislocki-dies-here-was-noted-scientist/
Obituary JAMA. 1956;162(18):1642-1644. doi:10.1001/jama.
1956.02970350058020
Paul Ehrlich (1854–1915)
1854 Born 14thMarch in Strehlen in Upper Silesia (then Prussia).
Educated at the Gymnasium at Breslau and subsequently at
the Universities of Breslau, Strassburg, Freiburg-im-Breisgau and
Leipzig
1876–1877 State examination as a medical doctor
1878 Obtained doctorate at University of Leipzig
Dissertation on theory and practice of staining animal tissues, in
particular as a means of studying oxygenation of the brain
1878–1887 Physician at Berlin Medical Clinic (Charité)
1882 Ehrlich published method of staining tubercle bacillus.
Gram method of staining bacteria derived from this
1882 Appointed Titular Professor
1887 Faculty of Medicine, University of Berlin, quali-
fied as Privatdozen/Lecturer based on Habilitation thesis
“Sauerstoffbedurfnis des Organismus.” Later appointed Associate
Professor and Senior House Physician to Charite Hospital in
Berlin
1887–1890 Travels in Egypt and establishment of a private labo-
ratory
1891–1895Worked with Robert Koch at the Institute of Infectious
Diseases in Berlin
1896 Director of the specially established Institute for Serum
Research and Testing
1899 Moved to Frankfurt am Main (director of the Institute of
Experimental Therapy)
1908 Nobel prize in Physiology or Medicine 1908 (together with
Ilya Mechnikov) “in recognition of their work on the theory of
immunity”
1914 Professor of Pharmacology at Frankfurt University
1915 Died from a Stroke (Bad Homburg, Germany)
Scientific contributions: Ehrlich made an impressive number
of contributions to several research fields including hematology,
immunology, chemotherapy and cancer research: the discovery
of mast cells (in his Ph.D. thesis), dye experiments that were
interpreted as some as early evidence for a mechanism pre-
venting some molecules from entering the brain, although he
himself did not accept this explanation (see text), major con-
tributions to the diagnosis of blood diseases, discoveries about
immunity to plant poisons and inheritance of acquired immu-
nity via breast-milk, development of quantitative standardization
methods for antiserum , the formulation of the Side-chain theory
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and the discovery of Salvarsan (first pathogen-targeted drug) for
treatment of syphilis, the first successful chemotherapy.
See also Dale (1954) and Hüntelmann (2010)
The official website of the Nobel prize (http://www.
nobelprize.org)
The Paul-Ehrlich-Institut (http://www.pei.de/EN/home/node.
html)
Max Lewandowsky (1876–1918)
1876 Born 26 June in Berlin, Germany
1893 Awarded his Matriculation Certificate from the Friedrichs
Gymnasium school in Berlin
1893 Began his studies at the University of Marburg under
Hermann Cohen
1898 State examination as a medical doctor from Halle-
Wittenberg University
1902 Habilitation at University of Berlin
1902–1904 Privat Docent in Berlin
1904 Studied Clinical Psychiatry with Nissl and Bonhofer in
Heidelberg
1904–1905 Studied psychiatry with Pierre Mari at the Bice¸tre
Clinic in Paris
1905 Physician consultant at the City Hospital in Berlin-
Friedrichshain
1907 Publication of Die Funktionen des zentralen Nervensystems
1908 Appointed full Professor
1910 Together with Alzheimer, founded the journal “Zeitschrift
fur die gesamte Neurologie und Psychiatrie” and a series
"Monographien aus dem Gesamtgebiete der Neurologie und
Psychiatrie”
1910–1914 Publication of textbook “Handbuch der Neurologie“ (5
volumes) of neurologyWritten by Lewandowsky himself (parts of
each chapter) together with 40 contemporary European neurolo-
gists
1912 Publication of Praktische Neurologie für Ärzte. Later edition
in 1919
1914–1917 Served at war hospitals during this period
1918 Died on 4th April in a Berlin sanatorium, probably com-
mitted suicide
Scientific contributions: His scientific inheritance contains
definitive studies of neurophysiology of breathing, CSF, neu-
roanatomy of breathing centers, function of the sympathetic
nervous system, cerebellum, discalculia and war psychosis. He
was active in the Berlin neurological centers. He is frequently
credited with having coined the term Blut-Hirnschranke”
(blood-brain barrier) but as discussed in this review there is
no evidence for this. He was also the author of the textbook
Praktische Neurologie für Ärzte.
Lina Stern (1878–1968)
Part I. Geneva, Switzerland (1898–1925)
1878 Born August 26th in Latvia
1898–1904 Student in the Medical Faculty at the University of
Geneva. Presented M.D. thesis in the field of physiology in 1904
1904–1914 Assistant, then first assistant in physiology. Research
on biological oxidation, results published in German Journal of
Biochemistry
1917 First studies on a barrier that slows down the penetration
into the brain of substances dissolved in blood plasma
1918 First ever woman promoted to Associate Professor (in
Physiological Chemistry) at the Department of Physiology
1921–1923 Coins the term barrier hemato-encephalic. This was
probably the first use of the term “blood-brain barrier,” although
she mainly studied what was later called the blood-cerebrospinal
fluid-barrier
1925 On receipt of an invitation to move her laboratory to
Moscow, an attempt by the local government to promote her to
full professor fails because of her leftish pro-revolutionary views
and the financial crisis in Geneva
Part II. Rise, fall and rehabilitation in the USSR (1925–1953)
1925 Professor at Moscow Medical University and affiliation to
several medical institutions
1925–1934 Difficult and slow adaptation to life in the Soviet
Union and several failed attempts to recover her previous position
in Geneva. Numerous reports on the blood-brain barrier (BBB)
and on the effects of blood solutes following their parenteral or
intra-ventricular injection
1929–1948 Director of the new Physiological Institute built and
financed by the People’s Commissariats of Education of Health,
After 1939 the institute became part of the USSR Academy of
Sciences. It was dismantled in 1948 (see below)
1934–1935 To mark 30 years of her scientific and educational
work, Stern received an honorary doctorate of Biological Sciences
and was awarded the title of “honored worker of science”
1939 First ever women elected full member of the USSR Academy
of Sciences
1942 Publication in Nature and in the British Medical Journal of
her article on the treatment of shock by direct action upon the
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vegetative nervous centers Another article printed in the West
duringWWII deals with the treatment of tetanus. During the war,
Stern was a member of the Jewish Anti-Fascist Committee (JAC)
organized in order to mobilize Jewish support for the USSR’s war
effort against Nazi Germany
1943–1945 Stalin Prize. Orders of the Red Banner and of the Red
Star. Elected as full member of the USSR Academy of Medical
Sciences
1947 Publication in a widely read medical journal of an
unfounded attack against research on the blood-brain barrier,
apparently an authorized signal from Stalin geopolitical reorien-
tation to start persecution of Jews
1948Closure of the Institute of Physiology and Stern “unmasked”
as an “anti-Pavlovian” in 1949 she was accused of being a member
of a Zionist organization, arrested and detained for 3 years and 10
months
1952 Secrete military trial of prominent members of the JAC.
Except Stern, all the accused were executed on August 12, 1952.
She was sentenced to five years internal exile in a small town in
Central Asia
1953 Shortly after the death of Stalin, Stern was set free and
allowed to return to Moscow. The same year she was reinstated
in the Academy. She died on March 7, 1968
See also Vein (2008); Dreifuss and Sigrist (2009); Wiesendanger
(2010)
Edwin Goldmann (1862–1913)
1862 Born 11th November in Burghersdorp, South Africa, Moved
to Breslau (Wroclaw) in Europe with his parents, sister and
brothers at age 14. Studied in Breslau, Freiburg and London
1887 Presented his dissertation “Experimental contributions to
the teaching of the cystinuria and sulfur excretion in the urine.”
in Freiburg
1888 Received his Medical degree in London, Assistant under
Prof. Weigert at the Pathological-Anatomical Institute in
Frankfurt-on-Main
1888 Assistant at the University Surgical Hospital in Freiburg
1889 Practicing surgeon in Freiburg and Basel
1891 Received his Habilitation and qualified as a privat-docent
1895 Appointed Extraordinary Professor and became surgeon to
the Deaconess’s Hospital in Freiburg
1898–1913 Chief Physician at the hospital of the Deaconess’s in
Freiburg in 1898
1906On 27th February married Lorna Lawrence Bosworth Smith
(daughter of a British peer) at Bingham’s Melcombe in Dorset.
Associate under Paul Ehrlich at the Institute for Experimental
Therapeutics, Frankfurt
1913 Ehrlich canvassed support from William Welch to estab-
lish an Institute for Vital Staining that he wished Goldmann to
head. Abandoned following Goldmann’s death and outbreak of
1st World War
1913 Died from cancer in Freiburg
Scientific contributions: During his time in Freiburg, in addi-
tion to his role as a physician, Goldmann worked in the field
of “physiological chemistry” investigating sulfur-containing com-
pounds in urine and later at Evangelical Sisters in the field
of cancer research. He significantly contributed to the blood-
brain barrier field by his often-cited experiments showing the
azo-dye trypan blue did not stain the brain when injected par-
enterally (Goldmann’s “First experiment”), but did when injected
intrathecally (Goldmann’s “Second experiment”).
Singer und F. T. Haneman: Goldmann, Edwin Ellen In: Jewish
Encyclopedia
http://de.wikipedia.org/wiki/Edwin_Goldmann
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